Lisata Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
LSTA on Nasdaq
Location
110 Allen Road, Second Floor, Basking Ridge, NJ

There are no Buy or Sell transactions made by insiders since 4/23/2024

Lisata Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Erkki Ruoslahti Director $3.56M Jan 9, 2023
David J. Mazzo President & CEO, Director $987K Jan 9, 2025
Steven S. Myers Director $668K Jan 10, 2022
Michael H. Davidson Director $627K Jan 10, 2022
Anne Clem Whitaker Director $546K Jan 10, 2022
Todd Girolamo CLO, SVP of Corp Dev $481K Jan 13, 2022
Peter G. Traber Director $446K Jan 10, 2022
Kristen K. Buck EVP, R&D and CMO $298K Jan 9, 2025
Mohammad Azab Director $218K Jan 9, 2025
Steven M. Klosk Director $192K Jan 9, 2025
Gregory B. Brown Director $191K Jan 9, 2025
Cynthia Louise Flowers Director $190K Jan 9, 2025
Heidi Henson Director $162K Jan 9, 2025
Tariq Imam SVP, Bus Dev, General Counsel $91.7K Feb 3, 2025
James Nisco SVP, Fin/Treas, Chief Actg Off $87.6K Jan 9, 2025
David Slack President & CBO, Director $61.7K Jan 9, 2023

Recent Insider Transactions by Companies or Individuals for Lisata Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.